Clinical trial
Phase 1 Safety and Dosimetry Study of 68Ga-R8760 in Patients With Adrenocortical Carcinoma and Healthy Volunteers
NCT05999292 is registered in ClinicalTrials.gov with Radionetics Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Safety and Dosimetry Study of 68Ga-R8760 in Patients With Adrenocortical Carcinoma and Healthy Volunteers
- Lead sponsor
- Radionetics Oncology
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- September 11, 2023
- Completion date
- May 23, 2024
- Enrollment
- 11 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.